-
Jio Platforms
1,423.80 1,423.80(%) -
NSE
1,766.00 1,640.25(%) -
Reliance Industries
1,156.60 1,152.30(%) -
Piramal Pharma
235.45 235.45(%) -
United Breweries
1,316.00 1,845.90(%) -
Larsen & Toubro
3,892.00 4,440.00(%) -
Billionbrains
190.80 227.00(%) -
Swiggy
183.05 174.30(%) -
Cholaman.Inv.&Fn
1,557.55 1,952.00(%) -
Syngene Intl.
418.75 678.00(%) -
HDFC Bank
687.15 1,017.90(%) -
Lenskart Solut.
697.50 725.00(%) -
HDFC AMC
2,317.50 2,901.00(%) -
Patanjali Foods
375.20 613.95(%) -
Ola Electric
37.44 51.84(%) -
One 97
1,640.50 1,856.50(%) -
Acutaas Chemical
3,686.00 1,571.20(%) -
Sahajanand Medi
462.10 347.50(%) -
Jubilant Ingrev.
581.55 535.30(%) -
FSN E-Commerce
345.45 351.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Sudeep Pharma Ltd Chemicals
- Indian Private
- BSE Code : 70661.0
- ISIN : INE0QPI01025
-
Today’s Low
1,029.90 -
Today’s High
1,124.60
-
Open
1,030.00 -
Perv Close
1,022.40 -
52W Low
524.05 -
52W High
1,378.00
Key Indicators
-
P/E(TTM)
108.46
-
Mar.Cap (₹Cr.)
12,638.95
-
Div & Yield %
0.00
-
Book Value(₹)
69.59
-
Debt-Equity Ratio
9.45
-
AGM Date
28-Oct-2026
-
EPS
10.29
-
P/E Ratio
108.46
Financials Ratios
-
Debt-Equity Ratio
0.28
-
Mar.Cap (₹Cr.)
12,638.95
-
RONW (%)
45.98
-
ROCE (%)
48.39
Score Board
-
Equity (₹ in Cr.)
11.29
-
BV (₹)
69.60
-
Sales( ₹ in Cr.)
338.51
-
NP (in Cr.)
107.43
-
NP Var(%)
12.0
-
Div%
0.0
-
CPS (₹)
10.10
-
EPS (₹)
9.50
-
Traded Value (₹ in Lakhs)
12,605.63
-
52 Week High
1,378.00
-
52 Week Low
524.05
-
Price BSE
1116.0
-
Price NSE
1,119.00
-
Market Capital( in Cr.)
12,605.63
-
P/C Ratio
110.10
-
P/E Ratio
117.30
-
Price Vs.BV
9.50
-
28-Oct-2026( 07:28)
Results - Announcements - Sudee... - <p>Sudeep Pharma Ltd share pri...
-
21-Oct-2026( 11:35)
Corporate News - Sudee... - <p>Sudeep Pharma Limited will...
-
07-Oct-2026( 06:17)
Corporate News - Sudee... - <p>Sudeep Pharma Limited infor...
-
05-Oct-2026( 05:42)
Corporate News - Sudee... - <p>Sudeep Pharma Limited annou...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 338.51 | 356.73 | 343.76 | 404.00 | 344.95 | 217.89 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 338.51 | 356.73 | 343.76 | 404.00 | 344.95 | 217.89 |
| Other Income | 38.50 | 8.38 | 8.20 | 11.18 | 8.08 | 3.67 |
| Stock Adjustments | 45.50 | 20.47 | -7.58 | 15.56 | 2.91 | 0.46 |
| Total Income | 422.51 | 385.58 | 344.38 | 430.74 | 355.94 | 222.02 |
| EXPENDITURE : | ||||||
| Raw Materials | 148.54 | 139.04 | 118.74 | 181.72 | 137.63 | 83.74 |
| Power and Fuel Cost | 7.97 | 7.26 | 7.30 | 8.07 | 9.52 | 6.10 |
| Employee Cost | 28.95 | 26.06 | 20.22 | 60.79 | 13.55 | 11.46 |
| Other Manufacturing Expenses | 23.81 | 22.96 | 18.93 | 27.61 | 41.60 | 16.56 |
| Selling and Administration Expenses | 45.96 | 43.99 | 30.81 | 43.86 | 71.85 | 52.29 |
| Miscellaneous Expenses | 8.34 | 5.06 | 7.26 | 8.26 | 5.57 | 2.41 |
| Employee Benefit Expenses | 28.95 | 26.06 | 20.22 | 60.79 | 13.55 | 11.46 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 263.57 | 244.37 | 203.25 | 330.31 | 279.71 | 172.56 |
| Operating Profit | 158.94 | 141.20 | 141.14 | 100.43 | 76.23 | 49.46 |
| Interest | 6.73 | 5.68 | 3.68 | 4.83 | 1.63 | 0.97 |
| Gross Profit | 152.21 | 135.52 | 137.46 | 95.60 | 74.60 | 48.49 |
| Depreciation | 7.11 | 6.12 | 5.15 | 4.83 | 4.19 | 3.53 |
| Profit Before Tax | 145.10 | 129.40 | 132.31 | 90.77 | 70.41 | 44.96 |
| Current Tax | 34.32 | 33.13 | 34.02 | 23.19 | 17.06 | 10.59 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 3.19 | 0.53 | 0.21 | 0.41 | 1.04 | -0.62 |
| Reported Net Profit | 107.58 | 95.75 | 98.08 | 67.17 | 52.31 | 34.99 |
| Extraordinary Items | 0.15 | 0.15 | 0.07 | 0.00 | 0.29 | 0.07 |
| Adjusted Net Profit | 107.43 | 95.60 | 98.01 | 67.17 | 52.02 | 34.92 |
| Adjustment below Net Profit | -0.03 | -0.94 | -0.36 | 0.05 | 0.00 | 0.00 |
| P & L Balance brought forward | 416.04 | 321.23 | 223.51 | 156.29 | 102.57 | 67.58 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 523.59 | 416.04 | 321.23 | 223.51 | 154.87 | 102.57 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 9.52 | 9.85 | 696.04 | 476.69 | 371.20 | 248.29 |
| Earnings Per Share(Adj)-Unit Curr | 9.52 | - | - | - | - | - |
| Book Value | 69.59 | 44.01 | 2,374.56 | 1,681.07 | 1,193.96 | 822.76 |
| Book Value(Adj)-Unit Curr | 69.59 | - | - | - | - | - |
